← Open Payments lookup

STEPHANIE KEILEN: Open Payments

NPI 1518399484 · CHARLOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$455 in 22 payments from 14 companies in 2025. Trend: 2023 $160 · 2024 $442 · 2025 $455

Food & beverage: $455
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$108
Axsome Therapeutics, Inc.2$53
Novo Nordisk Inc2$48
Eisai Inc.2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
AstraZeneca Pharmaceuticals LP2$33
Alkermes, Inc.1$29
PFIZER INC.1$21
GlaxoSmithKline, LLC.1$18
Aimmune Therapeutics, Inc.1$15

Products named: REXULTI, Auvelity, Leqembi, CAPLYTA, AIRSUPRA, VIVITROL, ABILIFY MAINTENA, Ozempic.

Industry payments across MI — which companies pay providers there.